Observational studyLipids in health and disease2021

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study.

Ichiro Komiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.